Bullfrog AI Holdings Inc

Bullfrog AI has a strong liquidity position, with $2.18 million in cash and equivalents and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The company's current ratio of 3.85 indicates that it has more than enough current assets to cover its current liabilities. However, the company's operating cash flow of -$5.52 million and free cash flow of -$6.49 million suggest significant cash outflows from operations. The company's profitability metrics are negative, with a return on equity of -304.17% and a return on assets of -231.38%. These figures are well below the industry median for biotechnology and medical research firms, indicating that Bullfrog AI is not currently generating returns for its shareholders or assets. The company's operating income of -$6.59 million and net income of -$6.49 million further underscore its unprofitable operations. Bullfrog AI's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic breakdown provided in the available data. The lack of geographic diversification could expose the company to regional economic or regulatory risks, though the extent of this risk is not quantified in the available data. The company's growth trajectory is not clearly defined in the available data, as there are no forward-looking revenue projections or historical growth rates provided. The company's current revenue of $116.67 million is not compared to prior periods, making it difficult to assess its growth performance. The absence of a clear growth narrative is a concern for investors seeking to understand the company's long-term potential. The risk assessment indicates that Bullfrog AI has low liquidity and dilution risk, with no immediate filing-based flags detected. The company's strong cash position and lack of long-term debt reduce the likelihood of near-term liquidity stress. However, the company's significant operating losses and negative cash flows from operations could increase the risk of future dilution if the company needs to raise additional capital. The company has not disclosed any recent equity issuances or dilution events in the available data. There are no recent filings or transcripts available in the provided data to assess Bullfrog AI's strategic direction or operational developments. The absence of recent disclosures limits the ability to evaluate the company's response to market conditions or its progress on key initiatives.